3 Geographic Atrophy Clinical Trials in Springdale, AR (2026)

Q: How do I join a clinical trial in Springdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Springdale research site will contact you.

Recruiting Geographic Atrophy Studies in Springdale

NCT07431281Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

The purpose of this study is to evaluate the efficacy and safety of sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in first-line (1L) Claudin18.2 (CLDN18.2)-positiv...

Springdale, AR2,130 participantsAstraZeneca

View Study Details

NCT06814509Recruiting

Delivering HOPE (Helping Women Optimize Prenatal Equity)

The overarching research question is: "Does the provision of healthy food (Delivering HOPE) during pregnancy reduce the proportion of women who experience excessive gestational weight gain compared wi...

Springdale, AR1,440 participantsUniversity of Arkansas

View Study Details

NCT06103864Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with investigator's choice chemot...

Springdale, AR625 participantsAstraZeneca

View Study Details

About Geographic Atrophy Clinical Trials in Springdale

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 3 geographic atrophy clinical trials recruiting participants in Springdale, AR. These studies are seeking a combined 4,195 participants. Research is being sponsored by AstraZeneca, University of Arkansas. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Springdale — FAQ

Are there geographic atrophy clinical trials in Springdale?

Yes, there are 3 geographic atrophy clinical trials currently recruiting in Springdale, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Springdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Springdale research site will contact you about next steps.

Are clinical trials in Springdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Springdale studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 3 active trials in Springdale are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 13, 2026 from ClinicalTrials.gov